Literature DB >> 22416074

The rise of cardiovascular medicine.

Eugene Braunwald1.   

Abstract

Modern cardiology was born at the turn of the nineteenth to twentieth centuries with three great discoveries: the X ray, the sphygmomanometer, and the electrocardiograph. This was followed by cardiac catheterization, which led to coronary angiography and to percutaneous coronary intervention. The coronary care units and early reperfusion reduced the early mortality owing to acute myocardial infarction, and the discovery of coronary risk factors led to the development of Preventive Cardiology. Other major advances include several cardiac imaging techniques, the birth and development of cardiac surgery, and the control of cardiac arrhythmias. The treatment of heart failure, although greatly improved, remains a challenge. Current cardiology practice is evidence-based and global in scope. Research and practice are increasingly conducted in cardiovascular centres and institutes. It is likely that in the future, a greater emphasis will be placed on prevention, which will be enhanced by genetic information.

Entities:  

Mesh:

Year:  2012        PMID: 22416074      PMCID: PMC3345543          DOI: 10.1093/eurheartj/ehr452

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  52 in total

1.  ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium.

Authors:  A Endo; M Kuroda; Y Tsujita
Journal:  J Antibiot (Tokyo)       Date:  1976-12       Impact factor: 2.649

2.  Review of early pacemaker development.

Authors:  R Elmqvist
Journal:  Pacing Clin Electrophysiol       Date:  1978-10       Impact factor: 1.976

3.  Classics in arteriosclerosis research: On experimental cholesterin steatosis and its significance in the origin of some pathological processes by N. Anitschkow and S. Chalatow, translated by Mary Z. Pelias, 1913.

Authors: 
Journal:  Arteriosclerosis       Date:  1983 Mar-Apr

4.  Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.

Authors:  M Mirowski; P R Reid; M M Mower; L Watkins; V L Gott; J F Schauble; A Langer; M S Heilman; S A Kolenik; R E Fischell; M L Weisfeldt
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245

5.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

6.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

7.  Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

Authors:  J N Cohn; D G Archibald; S Ziesche; J A Franciosa; W E Harston; F E Tristani; W B Dunkman; W Jacobs; G S Francis; K H Flohr
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

8.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  Beta-blockers in dilated cardiomyopathies: they work.

Authors:  F Waagstein; A Hjalmarson; K Swedeberg; I Wallentin
Journal:  Eur Heart J       Date:  1983-01       Impact factor: 29.983

10.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

View more
  15 in total

1.  Welcome to the ESC journal family.

Authors:  Thomas F Lüscher
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-04

Review 2.  Antiplatelet agents for the treatment of deep venous thrombosis.

Authors:  Carolina Dq Flumignan; Luis Cu Nakano; Jose Cc Baptista-Silva; Ronald Lg Flumignan
Journal:  Cochrane Database Syst Rev       Date:  2022-07-25

Review 3.  Principles of transthoracic echocardiographic evaluation.

Authors:  Anita C Boyd; Nelson B Schiller; Liza Thomas
Journal:  Nat Rev Cardiol       Date:  2015-04-28       Impact factor: 32.419

4.  Blood stasis syndrome of coronary heart disease: A perspective of modern medicine.

Authors:  Gui Yu; Jie Wang
Journal:  Chin J Integr Med       Date:  2013-07-27       Impact factor: 1.978

5.  Milestones in cardiovascular medicine: 10 or more?

Authors:  E E van der Wall
Journal:  Neth Heart J       Date:  2013-12       Impact factor: 2.380

6.  Atherosclerosis & ischaemic heart disease: Here to stay or gone tomorrow.

Authors:  Gjin Ndrepepa
Journal:  Indian J Med Res       Date:  2017-09       Impact factor: 2.375

7.  Evidence-based chinese medicine for hypertension.

Authors:  Jie Wang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-03       Impact factor: 2.629

8.  Zhen gan xi feng decoction, a traditional chinese herbal formula, for the treatment of essential hypertension: a systematic review of randomized controlled trials.

Authors:  Xingjiang Xiong; Xiaochen Yang; Bo Feng; Wei Liu; Lian Duan; Ao Gao; Haixia Li; Jizheng Ma; Xinliang Du; Nan Li; Pengqian Wang; Kelei Su; Fuyong Chu; Guohao Zhang; Xiaoke Li; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-20       Impact factor: 2.629

Review 9.  Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985).

Authors:  Matthias Barton; Johannes Grüntzig; Marc Husmann; Josef Rösch
Journal:  Front Cardiovasc Med       Date:  2014-12-29

10.  Trends in the treatment of hypertension from the perspective of traditional chinese medicine.

Authors:  Xingjiang Xiong; Xiaochen Yang; Wei Liu; Fuyong Chu; Pengqian Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.